Simplifying Global Compliance
Eli Lilly PET Drug Misbranded by Misleading Imagery, FDA Says
Eli Lilly has misbranded its radioactive PET drug Amyvid, approved for reviewing displays of brain scans using a black-and-white scale, by featuring a multi-colored brain image on a webpage advertisement and other promotional materials for the product, according to an FDA untitled letter.
To View This Article:
Buy This Article Now
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing